ATOMT — Atomtrace as Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- CZK166.17m
- CZK166.21m
- CZK21.32m
Annual cashflow statement for Atomtrace as, fiscal year end - December 31st, CZK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | CAS | CAS | CAS | CAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -8.36 | -16.9 | -20.2 | -18.4 | — |
Depreciation | |||||
Non-Cash Items | -0.247 | 0.027 | 0.463 | 0.285 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.21 | 0.098 | 0.598 | 5.79 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.18 | -16.5 | -18.9 | -12.2 | — |
Capital Expenditures | -0.47 | -0.1 | -0.1 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.372 | — | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.098 | -0.1 | -0.1 | 0 | — |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.016 | 17.3 | 20.7 | 11.2 | — |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7.27 | 0.667 | 1.77 | -1.02 | — |